Skip to main content
SpringerLink
Log in

Genetic testing may minimise liver injury risk for lumiracoxib

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Paulding CA, Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, Wright TM, Meyer J.HLA alleles associated with lumiracoxib-related liver injury may increase the safety profile of lumiracoxib. 11th Annual Congress of the European League Against Rheumatism: abstr. THU0031, 16 Jun 2010. Available from: URL: http://www.eular.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Genetic testing may minimise liver injury risk for lumiracoxib. React. Wkly. 1308, 7 (2010). https://doi.org/10.2165/00128415-201013080-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013080-00011

Keywords

Search

Navigation